Description

Portielje et al evaluated outcomes in adults with idiopathic thrombocytopenic purpura (ITP). This can help identify patients who may benefit from more aggressive or novel therapy. The authors are from Leiden University in The Netherlands.

To read more or access our algorithms and calculators, please log in or register.